Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII

References

• WangYLDanYYangDWThe genus Anemarrhena Bunge: a review on ethnopharmacology, phytochemistry and pharmacologyJ Ethnopharmacol20141531426024556224
   PubMed Web of Science ®Google Scholar
• ZhangJYMengZYZhangMYMaDSXuSXKodamaHEffect of six steroidal saponins isolated from anemarrhenae rhizoma on platelet aggregation and hemolysis in human bloodClin Chim Acta19992891–2798810556655
   PubMed Web of Science ®Google Scholar
• NakashimaNKimuraIKimuraMMatsuuraHIsolation of pseudo-prototimosaponin AIII from rhizomes of Anemarrhena asphodeloides and its hypoglycemic activity in streptozotocin-induced diabetic miceJ Nat Prod19935633453508482946
   PubMed Web of Science ®Google Scholar
• JiangWXGuoJXueRAnti-depressive activities and biotransformation of timosaponin B-III and its derivativesNat Prod Res201428181446145324749724
   PubMed Web of Science ®Google Scholar
• LimSMJeongJJKangGDKimKAChoiHSKimDHTimosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-kappa B and MAPK activation and restoring Th17/Treg cell balanceInt Immunopharmacol201525249350325698557
   PubMed Web of Science ®Google Scholar
• TundisRBonesiMMenichiniFLoizzoMRRecent knowledge on medicinal plants as source of cholinesterase inhibitors for the treatment of dementiaMini Rev Med Chem201616860561826156548
   PubMed Web of Science ®Google Scholar
• ChenJRJiaXHWangHYiYJWangJYLiYJTimosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathwayInt J Oncol20164852063207026984633
   PubMed Web of Science ®Google Scholar
• HuangHLChiangWLHsiaoPCTimosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cellsTumour Biol20153653489349725542232
   PubMedGoogle Scholar
• LeeBJungKKimDHTimosaponin AIII, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in micePharmacol Biochem Behav200993212112719426756
   PubMed Web of Science ®Google Scholar
• SyLKYanSCLokCNManRYCheCMTimosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cellsCancer Res20086824102291023719074891
   PubMed Web of Science ®Google Scholar
• LokCNSyLKLiuFLCheCMActivation of autophagy of aggregation-prone ubiquitinated proteins by timosaponin A-IIIJ Biol Chem201128636316843169621757721
   PubMed Web of Science ®Google Scholar
• FangMGuLGuGFangJFacile synthesis and antitumor activities of timosaponin AIII and its analogsJ Carbohydr Chem2012313187202
   Web of Science ®Google Scholar
• TsaiCHYangCWWangJYTimosaponin AIII suppresses hepatocyte growth factor-induced invasive activity through sustained ERK activation in breast cancer MDA-MB-231 cellsEvid Based Complement Alternat Med2013201342105123878598
   PubMed Web of Science ®Google Scholar
• KingFWFongSGriffinCTimosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stressPLoS One20094912
   Web of Science ®Google Scholar
• KangYJChungHJNamJWCytotoxic and antineoplastic activity of timosaponin A-III for human colon cancer cellsJ Nat Prod201174470170621370894
   PubMed Web of Science ®Google Scholar
• WangNFengYZhuMSiuFMNgKMCheCMA novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinomaBiochim Biophys Acta20131833122890289923906794
   PubMed Web of Science ®Google Scholar
• PanH-JNieX-QLiuDBianKEffects of four kinds of Chinese medicine monomer on growth of PANC-1 xenograft tumor and studying of molecular mechanismChina J Chin Mater Med2013382245248
   Google Scholar
• KimKMImARKimSHHyunJWChaeSTimosaponin AIII inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasisCancer Sci2016107218118826595378
   PubMed Web of Science ®Google Scholar
• JungOLeeJLeeYJTimosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and beta-catenin signaling pathwaysBioorg Med Chem Lett201626163963396727422337
   PubMed Web of Science ®Google Scholar
• LuLLiuYDingYPreparation of highly purified timosaponin AIII from rhizoma anemarrhenae through an enzymatic method combined with preparative liquid chromatographyNat Prod Res201630202364236727055070
   PubMed Web of Science ®Google Scholar
• LiuYPuYZhangTDingYWangBCaiZRapid and sensitive determination of timosaponin AIII in rat plasma by LC-MS/MS and its pharmacokinetic applicationInt J Mol Sci20131423656367023434663
   PubMed Web of Science ®Google Scholar
• LiCCuiJWangCEncapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studiesJ Pharm Pharmacol201163337638421749385
   PubMed Web of Science ®Google Scholar
• GuoB-HChengYWuWLinL-PLinD-HHPLC assay and pharmacokinetics and tissue distribution study of glycyrrhetinic acid liposomes modified with galactosylated lipidJ Liposome Res201222212012722313057
   PubMed Web of Science ®Google Scholar
• ChenHWuJSunMN-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcuminJ Liposome Res201222210010922007962
   PubMed Web of Science ®Google Scholar
• LiJChenJCaiB-CYangTPreparation, characterization and tissue distribution of brucine stealth liposomes with different lipid compositionPharm Dev Technol201318477277821780866
   PubMed Web of Science ®Google Scholar
• ChenJYanG-JHuR-RImproved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholineInt J Nanomedicine20122012735673577
   Google Scholar
• HuwylerJDreweJKraehenbuehlSTumor targeting using liposomal antineoplastic drugsInt J Nanomedicine200831212918488413
   PubMed Web of Science ®Google Scholar
• GabizonACataneRUzielyBProlonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomesCancer Res19945449879928313389
   PubMed Web of Science ®Google Scholar
• PapahadjopoulosDAllenTMGabizonASterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacyProc Natl Acad Sci U S A1991882411460114641763060
   PubMed Web of Science ®Google Scholar
• GabizonAMartinFPolyethylene glycol coated (pegylated) liposomal doxorubicin – rationale for use in solid tumoursDrugs19971997541521
   Google Scholar
• ChenW-LYuanZ-QLiuYLiposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitroInt J Nanomedicine2016201611325336
   Google Scholar
• YuK-FZhangW-QLuoL-MThe antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluationInt J Nanomedicine20132013824732485
   Google Scholar
• MengSSuBLiWIntegrin-targeted paclitaxel nanoliposomes for tumor therapyMed Oncol20112841180118720645030
   PubMed Web of Science ®Google Scholar
• EramoALottiFSetteGIdentification and expansion of the tumorigenic lung cancer stem cell populationCell Death Differ200815350451418049477
   PubMed Web of Science ®Google Scholar
• TangXGuoNXuLGouXMiMCD147/EMMPRIN: an effective therapeutic target for hepatocellular carcinomaJ Drug Target Epub2012829
   Web of Science ®Google Scholar
• SironenRKTammiMTammiRAuvinenPKAnttilaMKosmaVMHyaluronan in human malignanciesExp Cell Res2011317438339121134368
   PubMed Web of Science ®Google Scholar
• SneathRJSManghamDCThe normal structure and function of CD44 and its role in neoplasiaMol Pathol19985141912009893744
   PubMedGoogle Scholar
• CichyJPureEThe liberation of CD44J Cell Biol2003161583984312796473
   PubMed Web of Science ®Google Scholar
• NaorDWallach-DayanSBZahalkaMASionovRVInvolvement of CD44, a molecule with a thousand faces, in cancer disseminationSemin Cancer Biol200818426026718467123
   PubMed Web of Science ®Google Scholar
• LiuYSunJLianHCaoWWangYHeZFolate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distributionJ Pharm Sci201410351538154724619562
   PubMed Web of Science ®Google Scholar
• BushmanJVaughanASheihetLZhangZCostacheMKohnJFunctionalized nanospheres for targeted delivery of paclitaxelJ Control Release2013171331532123792807
   PubMed Web of Science ®Google Scholar
• GaneshSIyerAKMorrisseyDVAmijiMMHyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumorsBiomaterials201334133489350223410679
   PubMed Web of Science ®Google Scholar
• WangLSuWLiuZCD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinomaBiomaterials201233205107511422494888
   PubMed Web of Science ®Google Scholar
• ArabiLBadieeAMosaffaFJaafariMRTargeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicinJ Control Release2015220pt A27528626518722
   PubMed Web of Science ®Google Scholar
• PlattVMSzokaFCJrAnticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptorMol Pharm20085447448618547053
   PubMed Web of Science ®Google Scholar
• ParkMHKeumCGSongJYKimDChoCWA novel aqueous parenteral formulation of docetaxel using prodrugsInt J Pharm20144621–21724370840
   PubMedGoogle Scholar
• AlshaerWHillaireauHVergnaudJIsmailSFattalEFunctionalizing liposomes with anti-CD44 aptamer for selective targeting of cancer cellsBioconjug Chem20152671307131325343502
   PubMed Web of Science ®Google Scholar
• ZashikhinaNNVolokitinaMVKorzhikov-VlakhVASelf-assembled polypeptide nanoparticles for intracellular irinotecan deliveryEur J Pharm Sci201710911228735041
   PubMed Web of Science ®Google Scholar
• SongXWenYTZhuJLZhaoFZhangZXLiJThermoresponsive delivery of paclitaxel by beta-cyclodextrin-based poly(N-isopropylacrylamide) star polymer via inclusion complexationBiomacromolecules201617123957396327776208
   PubMed Web of Science ®Google Scholar
• LingLDuYIsmailMSelf-assembled liposomes of dual paclitaxel-phospholipid prodrug for anticancer therapyInt J Pharm20175261–2112228412448
   PubMedGoogle Scholar
• ChangMLuSZhangFRGD-modified pH-sensitive liposomes for docetaxel tumor targetingColloids Surf B Biointerfaces201512917518225851582
   PubMed Web of Science ®Google Scholar
• YanFWuHLiuHMolecular imaging-guided photothermal/photodynamic therapy against tumor by iRGD-modified indocyanine green nanoparticlesJ Control Release201622421722826739551
   PubMed Web of Science ®Google Scholar
• YoonHJLeeHSLimJYParkJHLiposomal indocyanine green for enhanced photothermal therapyACS Appl Mater Interfaces2017975683569128152314
   PubMed Web of Science ®Google Scholar
• SonaliSSinghRPSharmaGRGD-TPGS decorated theranostic liposomes for brain targeted deliveryColloids Surf B Biointerfaces201614712914127497076
   PubMed Web of Science ®Google Scholar
• ZhangSWangJPanJBaicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in ratsDrug Deliv20162393696370327749105
   PubMed Web of Science ®Google Scholar
• LiuMJinSYanHDuSEffect of oxymatrine HSPC liposomes on improving bioavailability, liver target distribution and hepatoprotective activity of oxymatrineEur J Pharm Sci201710421222028389275
   PubMed Web of Science ®Google Scholar
• ZhangLHanLSunXGaoDQinJWangJThe use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid BFitoterapia201283467868922391022
   PubMed Web of Science ®Google Scholar
• ChuCXuPZhaoHEffect of surface ligand density on cytotoxicity and pharmacokinetic profile of docetaxel loaded liposomesAsian J Pharm Sci2016115655661
   Web of Science ®Google Scholar
• FeiWZhangYHanSRGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinomaInt J Pharm20175191–225026228109899
   PubMed Web of Science ®Google Scholar
• ZuoTGuanYChangMRGD(Arg-Gly-Asp) internalized docetaxel-loaded pH sensitive liposomes: preparation, characterization and antitumor efficacy in vivo and in vitroColloids Surf B Biointerfaces2016147909927497073
   PubMed Web of Science ®Google Scholar
• PirolloKFChangEHDoes a targeting ligand influence nanoparticle tumor localization or uptake?Trends Biotechnol2008261055255818722682
   PubMed Web of Science ®Google Scholar
• van der MeelRVehmeijerLJKokRJStormGvan GaalEVLigand-targeted particulate nanomedicines undergoing clinical evaluation: current statusAdv Drug Deliv Rev201365101284129824018362
   PubMed Web of Science ®Google Scholar
• FarajiAHWipfPNanoparticles in cellular drug deliveryBioorg Med Chem20091782950296219299149
   PubMed Web of Science ®Google Scholar
• HeCHuYYinLTangCYinCEffects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticlesBiomaterials201031133657366620138662
   PubMed Web of Science ®Google Scholar
• XiaoKLiYLuoJThe effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticlesBiomaterials201132133435344621295849
   PubMed Web of Science ®Google Scholar
• HansenCBKaoGYMoaseEHZalipskySAllenTMAttachment of antibodies to sterically stabilized liposomes – evaluation, comparison and optimization of coupling proceduresBiochim Biophys Acta Biomembr199512392133144
   PubMed Web of Science ®Google Scholar
• ZhengXZhouFWuBChenWRXingDEnhanced tumor treatment using biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injectionMol Pharm20129351452222332810
   PubMed Web of Science ®Google Scholar
• WuZTQiXMShengJJTimosaponin A3 induces hepatotoxicity in rats through inducing oxidative stress and down-regulating bile acid transportersActa Pharmacol Sin20143591188119825087997
   PubMed Web of Science ®Google Scholar